Evaluation of drug interaction software to identify alerts for transplant medications

Wendy D. Smith, Randy C. Hatton, Amy L. Fann, Maher A. Baz, Bruce Kaplan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

BACKGROUND: The ability of computerized physician order entry (CPOE) systems to identify clinically significant drug interactions is dependent upon the integrity of the drug information populating the software. A CPOE system with incomplete or inaccurate drug information will fail to identify clinically important drug interactions and, therefore, fail to reduce preventable adverse drug events (pADEs). OBJECTIVE: To evaluate, from the preservers' perspective, the ability of a common drug interaction database to identify clinically important drug interactions involving drugs used in transplantation. METHODS: The clinical significance of drug interactions involving 5 transplant drugs was evaluated by an expert panel to determine whether alerts should be generated for physicians not involved in the transplant at the time of order entry. Drug interactions included in the analysis were generated from the expert panel, a common drug interaction database, and 2 standard drug interaction references. Responses on the clinical significance were used to calculate the sensitivity, specificity, and positive and negative predictive values for each severity setting of a common electronic drug interaction database. RESULTS: Overall, the database failed to identify approximately 70% of interactions considered significant by the expert panel. Of the alerts that were generated, >85% were considered clinically significant. The database was most deficient in identifying interactions resulting from additive toxicity. CONCLUSIONS: To expect a decrease in pADEs caused by drug interactions, the information used to populate CPOE systems must be validated. Establishing consistency and integrity of this information may be a future role for pharmacists.

Original languageEnglish (US)
Pages (from-to)45-50
Number of pages6
JournalAnnals of Pharmacotherapy
Volume39
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Drug Interactions
Software
Transplants
Medical Order Entry Systems
Pharmaceutical Databases
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Databases
Pharmacists
Transplantation
Physicians
Sensitivity and Specificity

Keywords

  • Computerized physician order entry
  • Drug interaction software
  • Drug interactions
  • Transplantation

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Evaluation of drug interaction software to identify alerts for transplant medications. / Smith, Wendy D.; Hatton, Randy C.; Fann, Amy L.; Baz, Maher A.; Kaplan, Bruce.

In: Annals of Pharmacotherapy, Vol. 39, No. 1, 01.2005, p. 45-50.

Research output: Contribution to journalArticle

Smith, Wendy D. ; Hatton, Randy C. ; Fann, Amy L. ; Baz, Maher A. ; Kaplan, Bruce. / Evaluation of drug interaction software to identify alerts for transplant medications. In: Annals of Pharmacotherapy. 2005 ; Vol. 39, No. 1. pp. 45-50.
@article{16c22c6ae2ec4d429873e2f838601222,
title = "Evaluation of drug interaction software to identify alerts for transplant medications",
abstract = "BACKGROUND: The ability of computerized physician order entry (CPOE) systems to identify clinically significant drug interactions is dependent upon the integrity of the drug information populating the software. A CPOE system with incomplete or inaccurate drug information will fail to identify clinically important drug interactions and, therefore, fail to reduce preventable adverse drug events (pADEs). OBJECTIVE: To evaluate, from the preservers' perspective, the ability of a common drug interaction database to identify clinically important drug interactions involving drugs used in transplantation. METHODS: The clinical significance of drug interactions involving 5 transplant drugs was evaluated by an expert panel to determine whether alerts should be generated for physicians not involved in the transplant at the time of order entry. Drug interactions included in the analysis were generated from the expert panel, a common drug interaction database, and 2 standard drug interaction references. Responses on the clinical significance were used to calculate the sensitivity, specificity, and positive and negative predictive values for each severity setting of a common electronic drug interaction database. RESULTS: Overall, the database failed to identify approximately 70{\%} of interactions considered significant by the expert panel. Of the alerts that were generated, >85{\%} were considered clinically significant. The database was most deficient in identifying interactions resulting from additive toxicity. CONCLUSIONS: To expect a decrease in pADEs caused by drug interactions, the information used to populate CPOE systems must be validated. Establishing consistency and integrity of this information may be a future role for pharmacists.",
keywords = "Computerized physician order entry, Drug interaction software, Drug interactions, Transplantation",
author = "Smith, {Wendy D.} and Hatton, {Randy C.} and Fann, {Amy L.} and Baz, {Maher A.} and Bruce Kaplan",
year = "2005",
month = "1",
doi = "10.1345/aph.1E331",
language = "English (US)",
volume = "39",
pages = "45--50",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "1",

}

TY - JOUR

T1 - Evaluation of drug interaction software to identify alerts for transplant medications

AU - Smith, Wendy D.

AU - Hatton, Randy C.

AU - Fann, Amy L.

AU - Baz, Maher A.

AU - Kaplan, Bruce

PY - 2005/1

Y1 - 2005/1

N2 - BACKGROUND: The ability of computerized physician order entry (CPOE) systems to identify clinically significant drug interactions is dependent upon the integrity of the drug information populating the software. A CPOE system with incomplete or inaccurate drug information will fail to identify clinically important drug interactions and, therefore, fail to reduce preventable adverse drug events (pADEs). OBJECTIVE: To evaluate, from the preservers' perspective, the ability of a common drug interaction database to identify clinically important drug interactions involving drugs used in transplantation. METHODS: The clinical significance of drug interactions involving 5 transplant drugs was evaluated by an expert panel to determine whether alerts should be generated for physicians not involved in the transplant at the time of order entry. Drug interactions included in the analysis were generated from the expert panel, a common drug interaction database, and 2 standard drug interaction references. Responses on the clinical significance were used to calculate the sensitivity, specificity, and positive and negative predictive values for each severity setting of a common electronic drug interaction database. RESULTS: Overall, the database failed to identify approximately 70% of interactions considered significant by the expert panel. Of the alerts that were generated, >85% were considered clinically significant. The database was most deficient in identifying interactions resulting from additive toxicity. CONCLUSIONS: To expect a decrease in pADEs caused by drug interactions, the information used to populate CPOE systems must be validated. Establishing consistency and integrity of this information may be a future role for pharmacists.

AB - BACKGROUND: The ability of computerized physician order entry (CPOE) systems to identify clinically significant drug interactions is dependent upon the integrity of the drug information populating the software. A CPOE system with incomplete or inaccurate drug information will fail to identify clinically important drug interactions and, therefore, fail to reduce preventable adverse drug events (pADEs). OBJECTIVE: To evaluate, from the preservers' perspective, the ability of a common drug interaction database to identify clinically important drug interactions involving drugs used in transplantation. METHODS: The clinical significance of drug interactions involving 5 transplant drugs was evaluated by an expert panel to determine whether alerts should be generated for physicians not involved in the transplant at the time of order entry. Drug interactions included in the analysis were generated from the expert panel, a common drug interaction database, and 2 standard drug interaction references. Responses on the clinical significance were used to calculate the sensitivity, specificity, and positive and negative predictive values for each severity setting of a common electronic drug interaction database. RESULTS: Overall, the database failed to identify approximately 70% of interactions considered significant by the expert panel. Of the alerts that were generated, >85% were considered clinically significant. The database was most deficient in identifying interactions resulting from additive toxicity. CONCLUSIONS: To expect a decrease in pADEs caused by drug interactions, the information used to populate CPOE systems must be validated. Establishing consistency and integrity of this information may be a future role for pharmacists.

KW - Computerized physician order entry

KW - Drug interaction software

KW - Drug interactions

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=11144222284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144222284&partnerID=8YFLogxK

U2 - 10.1345/aph.1E331

DO - 10.1345/aph.1E331

M3 - Article

C2 - 15598964

AN - SCOPUS:11144222284

VL - 39

SP - 45

EP - 50

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 1

ER -